Biotech Values

[DewDiligence]

>Dr. Dieterich said that he thought the recently-reported in-vitro ( replicon system ) results showing a negative interaction between riba and NM-283 would not carry over into in-vivo studies. I'd be more inclined to trust him on this if not for some of the other questionable statements he made.<

That was exactly my reaction. During the webcast, I was waiting for someone other than Dieterich to second this prediction, but no one did. That’s why I did not include Dieterich’s prediction in my webcast summary.